ABCB1 and leukemia: A potential explanation is suggested by our observation that exposure of leukemia cells with primed ABCB1 enhancers to daunorubicin leads to rapid and substantial upregulation of ABCB1, with escape of a leukemia cell subpopulation from the effects of drug efflux pump inhibition.